Plasma glucose and pre-eclampsia. 1996

K S Khan, and S Daya
Department of Obstetrics and Gynaecology, Aga Khan University Medical Center, Karachi, Pakistan. khank@fhs.mcmaster.ca

OBJECTIVE To determine whether there is a relationship between plasma glucose level in a glucose screening test and the occurrence of pre-eclampsia in non-diabetic pregnant women. METHODS All pregnant non-diabetic women attending the antenatal clinic at the Aga Khan University Medical Center were screened with a 75 g-2 h glucose challenge test (GCT). From 1988-90, a data base of 1316 cases was compiled for use in this study. Of these, 67 had to be excluded because of one or more abnormal levels in the 75 g-3 h oral glucose tolerance test (GTT) that required treatment to maintain euglycemia. Among the remaining patients (n = 1249) who had no evidence of glucose intolerance and were included in the analysis, there were 42 cases of pre-eclampsia. The association between pre-eclampsia and plasma glucose level in the GCT was evaluated using logistic regression analysis that adjusted for effects of age and gravidity. RESULTS The odds of having pre-eclampsia were increased by 20% (95% confidence interval 0%-44%) per mmol/l rise in plasma glucose level in the GCT. The same statistic for age was 9% (95% confidence interval 2%-17%), and for primigravidity it was 210% (95% confidence interval 55%-517%). There was no significant interaction between these variables. CONCLUSIONS Minor degrees of glucose intolerance, age and primigravidity are associated with a higher occurrence of pre-eclampsia in non-diabetic pregnant women.

UI MeSH Term Description Entries
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D016015 Logistic Models Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor. Logistic Regression,Logit Models,Models, Logistic,Logistic Model,Logistic Regressions,Logit Model,Model, Logistic,Model, Logit,Models, Logit,Regression, Logistic,Regressions, Logistic

Related Publications

K S Khan, and S Daya
April 2001, Scandinavian journal of clinical and laboratory investigation,
K S Khan, and S Daya
March 1994, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
K S Khan, and S Daya
August 1974, Lancet (London, England),
K S Khan, and S Daya
March 1973, The Journal of obstetrics and gynaecology of the British Commonwealth,
K S Khan, and S Daya
May 1977, Lancet (London, England),
K S Khan, and S Daya
March 1978, British medical journal,
K S Khan, and S Daya
November 1988, Ginekologia polska,
K S Khan, and S Daya
July 1977, Lancet (London, England),
K S Khan, and S Daya
June 1978, British medical journal,
Copied contents to your clipboard!